TY  - GEN
AU  - Severs,M
AU  - Oldenburg,B
AU  - van Bodegraven,A A
AU  - Siersema,P D
AU  - Mangen,M-J J
TI  - The Economic Impact of the Introduction of Biosimilars in Inflammatory Bowel Disease
SN  - 1876-4479
PY  - 2017///1107
KW  - Adalimumab
KW  - economics
KW  - Biosimilar Pharmaceuticals
KW  - Colitis, Ulcerative
KW  - drug therapy
KW  - Computer Simulation
KW  - Crohn Disease
KW  - Drug Costs
KW  - statistics & numerical data
KW  - Drug Prescriptions
KW  - Drug Substitution
KW  - Gastrointestinal Agents
KW  - Hospitalization
KW  - Humans
KW  - Infliximab
KW  - Models, Economic
KW  - Netherlands
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/ecco-jcc/jjw153
ER  -